Celgene Corp. buy piccolo90
Start price
16.12.16
/
50%
€105.69
Target price
24.01.17
€125.41
Performance (%)
-4.42%
End price
24.01.17
€101.02
Summary
This prediction ended on 24.01.17 with a price of €101.02. With a performance of -4.42%, the BUY prediction by piccolo90 finished with a loss. piccolo90 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% | 70.602% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% | 103.322% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% | 44.593% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% | 64.741% |
Comments by piccolo90 for this prediction
In the thread Celgene Corp. diskutieren
piccolo90 stimmt der Outperform-Einschätzung der institutionellen Analysten zu
piccolo90 stimmt am 16.12.2016 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 139.04$ zu.
(Vom Mitglied beendet)